Luxeptinib
Luxeptinib (CG-806) is an orally available, non-covalent pan-FLT3/BTK inhibitor. It demonstrates potent reversible inhibition, inducing cell death in AML models through apoptosis, autophagy, and cell cycle arrest in preclinical studies.
Product Specifications
CAS Number
1616428-23-9
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Smiles
Cc1c[nH]c (n1) -c1ccc (c2CNC (=O) c12) -c1ccc (NC (=O) Nc2c (F) cc (F) cc2F) cc1F
Molecular Formula
C25H17F4N5O2
Molecular Weight
495.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15106210 1 Vial
Lentiviral mouse B230219D22Rik shRNA (UAS) - Lentiviral mouse B230219D22Rik shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details 
I0597 96 Tests
UDP-N-acetylglucosamine Transporter (SLC35A3) Rat ELISA Kit
Sign In for Pricing
View Details 
BPC74956-01 50 mg
4- (2-Methylpropane-2-sulfonyl) benzene-1-sulfonyl chloride
Sign In for Pricing
View Details